Levente Kuthi

401 total citations
37 papers, 160 citations indexed

About

Levente Kuthi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Levente Kuthi has authored 37 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Levente Kuthi's work include Renal and related cancers (14 papers), Renal cell carcinoma treatment (13 papers) and Cancer Genomics and Diagnostics (4 papers). Levente Kuthi is often cited by papers focused on Renal and related cancers (14 papers), Renal cell carcinoma treatment (13 papers) and Cancer Genomics and Diagnostics (4 papers). Levente Kuthi collaborates with scholars based in Hungary, United States and Czechia. Levente Kuthi's co-authors include Béla Iványi, Zoltán Bajory, László Pajor, I Németh, Zoltán Varga, Ibolya Laczó, Áron Somorácz, Tamás Micsík, István Sejben and Janina Kulka and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Human Pathology.

In The Last Decade

Levente Kuthi

26 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levente Kuthi Hungary 7 97 77 51 27 27 37 160
M Tan Singapore 7 51 0.5× 112 1.5× 52 1.0× 25 0.9× 40 1.5× 9 182
Kate Weiss United States 5 73 0.8× 61 0.8× 31 0.6× 42 1.6× 40 1.5× 7 143
Lynn J. Poole Perry United States 7 89 0.9× 58 0.8× 17 0.3× 52 1.9× 42 1.6× 11 255
Haijun Tang China 10 43 0.4× 69 0.9× 55 1.1× 52 1.9× 46 1.7× 28 226
Weigang Xiu China 9 51 0.5× 44 0.6× 16 0.3× 31 1.1× 122 4.5× 25 200
Junlong Xu China 5 48 0.5× 43 0.6× 9 0.2× 26 1.0× 36 1.3× 11 138
Fabian Rössler Switzerland 6 45 0.5× 64 0.8× 29 0.6× 52 1.9× 77 2.9× 29 171
Qingshan Du China 8 156 1.6× 227 2.9× 143 2.8× 40 1.5× 27 1.0× 12 319
Arthi Sridhar United States 7 43 0.4× 103 1.3× 25 0.5× 21 0.8× 36 1.3× 30 198
Kei Daizumoto Japan 8 79 0.8× 63 0.8× 37 0.7× 63 2.3× 38 1.4× 39 195

Countries citing papers authored by Levente Kuthi

Since Specialization
Citations

This map shows the geographic impact of Levente Kuthi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levente Kuthi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levente Kuthi more than expected).

Fields of papers citing papers by Levente Kuthi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levente Kuthi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levente Kuthi. The network helps show where Levente Kuthi may publish in the future.

Co-authorship network of co-authors of Levente Kuthi

This figure shows the co-authorship network connecting the top 25 collaborators of Levente Kuthi. A scholar is included among the top collaborators of Levente Kuthi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levente Kuthi. Levente Kuthi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuthi, Levente, et al.. (2025). Gastric Adenocarcinoma with Enteroblastic Differentiation. Pathobiology. 92(3). 169–179.
3.
Saha, Sajib, Janardhan Vignarajan, Csaba Tóth, et al.. (2024). An Artificial Intelligent System for Prostate Cancer Diagnosis in Whole Slide Images. Journal of Medical Systems. 48(1). 101–101.
4.
Sükösd, Farkas, et al.. (2024). Novel method for detecting frequent TERT promoter hot spot mutations in bladder cancer samples. Clinical and Experimental Medicine. 24(1). 192–192.
5.
Kuthi, Levente, et al.. (2024). Colonic Tubular Adenoma with Clear Cell Change: Case Report with Whole-Exome Sequencing and Updated Review of the Literature. Pathobiology. 91(5). 375–381. 1 indexed citations
6.
Kuthi, Levente, Tamás Zombori, László Tiszlavicz, et al.. (2024). Emerging human pulmonary dirofilariasis in Hungary: a single center experience. Diagnostic Pathology. 19(1). 85–85. 2 indexed citations
7.
Kuthi, Levente, et al.. (2023). Angiomyolipoma of the kidney—Clinicopathological analysis of 52 cases. Pathology & Oncology Research. 28. 1610831–1610831. 7 indexed citations
8.
Kuthi, Levente, et al.. (2023). TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(5). 861–868. 6 indexed citations
9.
Micsík, Tamás, Tamás Tornóczky, Levente Kuthi, et al.. (2023). Alterations of miRNA Expression in Diffuse Hyperplastic Perilobar Nephroblastomatosis: Mapping the Way to Understanding Wilms’ Tumor Development and Differential Diagnosis. International Journal of Molecular Sciences. 24(10). 8793–8793. 5 indexed citations
10.
Kuthi, Levente, et al.. (2023). Az alsó végtag myxoinflammatoricus fibroblastos sarcomája. Orvosi Hetilap. 164(41). 1637–1641. 1 indexed citations
11.
Kuthi, Levente, et al.. (2023). Húgyhólyag-schistosomiasis.. Orvosi Hetilap. 164(48). 1920–1924.
12.
Kuthi, Levente, et al.. (2023). Az invazív urothelsejtes carcinoma morfológiai variánsai.. Orvosi Hetilap. 164(40). 1567–1582. 1 indexed citations
13.
Somorácz, Áron, et al.. (2023). Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary. Pathobiology. 90(5). 322–332. 2 indexed citations
14.
Szentkereszty, Márton, et al.. (2023). Penile melanoma: a pathological report of two cases. Diagnostic Pathology. 18(1). 117–117.
15.
Kuthi, Levente, et al.. (2023). Novel concept of Wilms’ tumor development: involvement of pluripotential cells of ureteric bud. Human Pathology. 138. 34–40. 1 indexed citations
16.
Újfaludi, Zsuzsanna, et al.. (2022). The clinical significance of epigenetic and RNAPII variabilities occurring in clear cell renal cell carcinoma as a potential prognostic marker. Translational Oncology. 20. 101420–101420. 2 indexed citations
17.
Újfaludi, Zsuzsanna, et al.. (2022). Novel Diagnostic Value of Driver Gene Transcription Signatures to Characterise Clear Cell Renal Cell Carcinoma, ccRCC. Pathology & Oncology Research. 28. 1610345–1610345. 1 indexed citations
18.
Alaghehbandan, Reza, Joanna Rogala, Tomáš Vaněček, et al.. (2021). Clear cell renal cell carcinoma with prominent microvascular hyperplasia: Morphologic, immunohistochemical and molecular-genetic analysis of 7 sporadic cases. Annals of Diagnostic Pathology. 56. 151871–151871. 1 indexed citations
19.
Kuthi, Levente, et al.. (2020). Inflammatory Myofibroblastic Tumors in the Uterus: Childhood-Case Report and Review of the Literature. Frontiers in Pediatrics. 8. 36–36. 9 indexed citations
20.
Somorácz, Áron, Levente Kuthi, Tamás Micsík, et al.. (2019). Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis. Pathology & Oncology Research. 26(3). 1767–1776. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026